270 related articles for article (PubMed ID: 11336660)
21. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors.
Breton R; Housset D; Mazza C; Fontecilla-Camps JC
Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577
[TBL] [Abstract][Full Text] [Related]
22. Amino acid substitution of arginine 80 in 17beta-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics.
McKeever BM; Hawkins BK; Geissler WM; Wu L; Sheridan RP; Mosley RT; Andersson S
Biochim Biophys Acta; 2002 Nov; 1601(1):29-37. PubMed ID: 12429500
[TBL] [Abstract][Full Text] [Related]
23. Reactivation of human placental 17 beta,20 alpha-hydroxysteroid dehydrogenase affinity alkylated by estrone 3-(bromoacetate): topographic studies with 16 alpha-(bromoacetoxy)estradiol 3-(methyl ether).
Thomas JL; LaRochelle MC; Asibey-Berko E; Strickler RC
Biochemistry; 1985 Sep; 24(20):5361-7. PubMed ID: 3865689
[TBL] [Abstract][Full Text] [Related]
24. DHEA and peripheral androgen and estrogen formation: intracinology.
Labrie F; Bélanger A; Simard J; Van Luu-The ; Labrie C
Ann N Y Acad Sci; 1995 Dec; 774():16-28. PubMed ID: 8597456
[No Abstract] [Full Text] [Related]
25. Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation.
Negri M; Recanatini M; Hartmann RW
PLoS One; 2010 Aug; 5(8):e12026. PubMed ID: 20706575
[TBL] [Abstract][Full Text] [Related]
26. Kinetic and mechanistic properties of biotin sulfoxide reductase.
Pollock VV; Barber MJ
Biochemistry; 2001 Feb; 40(5):1430-40. PubMed ID: 11170471
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Le Lain R; Nicholls PJ; Smith HJ; Maharlouie FH
J Enzyme Inhib; 2001 Jan; 16(1):35-45. PubMed ID: 11496833
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1.
Herman BE; Kiss A; Wölfling J; Mernyák E; Szécsi M; Schneider G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1271-1286. PubMed ID: 31307240
[TBL] [Abstract][Full Text] [Related]
29. Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer.
Wang X; Gérard C; Thériault JF; Poirier D; Doillon CJ; Lin SX
J Mol Cell Biol; 2015 Dec; 7(6):568-79. PubMed ID: 25966904
[TBL] [Abstract][Full Text] [Related]
30. Kinetic properties of human placental glucose-6-phosphate dehydrogenase.
Ozer N; Aksoy Y; Ogüs IH
Int J Biochem Cell Biol; 2001 Mar; 33(3):221-6. PubMed ID: 11311853
[TBL] [Abstract][Full Text] [Related]
31. The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase.
Legeza B; Balázs Z; Nashev LG; Odermatt A
Endocrinology; 2013 Jan; 154(1):205-13. PubMed ID: 23183177
[TBL] [Abstract][Full Text] [Related]
32. Testosterone dehydrogenase activity in koala liver: characterisation of cofactor and steroid substrate differences.
Stupans I; Kong S; Kirlich A; McKinnon RA; Murray M
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Feb; 125(2):245-50. PubMed ID: 11790346
[TBL] [Abstract][Full Text] [Related]
33. [Serum and tissue 17 beta hydroxysteroid dehydrogenase and estrogens in hydatidiform mole].
Massart C; Le Pogamp C; Nicol M
J Clin Chem Clin Biochem; 1983 Feb; 21(2):77-82. PubMed ID: 6302196
[TBL] [Abstract][Full Text] [Related]
34. Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase.
Endo S; Miyagi N; Matsunaga T; Hara A; Ikari A
Biochem Biophys Res Commun; 2016 Mar; 472(1):231-6. PubMed ID: 26920053
[TBL] [Abstract][Full Text] [Related]
35. Characterization of 17beta-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe.
Steckelbroeck S; Stoffel-Wagner B; Reichelt R; Schramm J; Bidlingmaier F; Siekmann L; Klingmüller D
J Neuroendocrinol; 1999 Jun; 11(6):457-64. PubMed ID: 10336727
[TBL] [Abstract][Full Text] [Related]
36. 17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.
Day JM; Foster PA; Tutill HJ; Parsons MF; Newman SP; Chander SK; Allan GM; Lawrence HR; Vicker N; Potter BV; Reed MJ; Purohit A
Int J Cancer; 2008 May; 122(9):1931-40. PubMed ID: 18183589
[TBL] [Abstract][Full Text] [Related]
37. Characterization of hamster NAD+-dependent 3(17)β-hydroxysteroid dehydrogenase belonging to the aldo-keto reductase 1C subfamily.
Endo S; Noda M; Ikari A; Tatematsu K; El-Kabbani O; Hara A; Kitade Y; Matsunaga T
J Biochem; 2015 Nov; 158(5):425-34. PubMed ID: 26002966
[TBL] [Abstract][Full Text] [Related]
38. Kinetic studies on the enzymes involved in estrogen biosynthesis and evidence for existence of a single 5-Ene-3beta-hydroxysteroid dehydrogenase complex in the ovary of the freshwater catfish, Clarias batrachus.
Singh S; Singh TP
Gen Comp Endocrinol; 1985 Jun; 58(3):458-63. PubMed ID: 2989083
[TBL] [Abstract][Full Text] [Related]
39. Mimicking postmenopausal steroid metabolism in breast cancer cell culture: Differences in response to DHEA or other steroids as hormone sources.
Xu D; Lin SX
J Steroid Biochem Mol Biol; 2016 Jul; 161():92-100. PubMed ID: 26200948
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells.
MacIndoe JH; Hinkhouse M; Woods G
Breast Cancer Res Treat; 1990 Oct; 16(3):261-72. PubMed ID: 1964814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
